Your browser doesn't support javascript.
loading
Emergence of a multidrug-resistant and virulent Streptococcus pneumoniae lineage mediates serotype replacement after PCV13: an international whole-genome sequencing study.
Lo, Stephanie W; Mellor, Kate; Cohen, Robert; Alonso, Alba Redin; Belman, Sophie; Kumar, Narender; Hawkins, Paulina A; Gladstone, Rebecca A; von Gottberg, Anne; Veeraraghavan, Balaji; Ravikumar, K L; Kandasamy, Rama; Pollard, Sir Andrew J; Saha, Samir K; Bigogo, Godfrey; Antonio, Martin; Kwambana-Adams, Brenda; Mirza, Shaper; Shakoor, Sadia; Nisar, Imran; Cornick, Jennifer E; Lehmann, Deborah; Ford, Rebecca L; Sigauque, Betuel; Turner, Paul; Moïsi, Jennifer; Obaro, Stephen K; Dagan, Ron; Diawara, Idrissa; Skoczynska, Anna; Wang, Hui; Carter, Philip E; Klugman, Keith P; Rodgers, Gail; Breiman, Robert F; McGee, Lesley; Bentley, Stephen D; Muñoz-Almagro, Carmen; Varon, Emmanuelle.
Afiliación
  • Lo SW; Parasites and Microbes Programme, Wellcome Sanger Institute, Hinxton, UK. Electronic address: stephanie.lo@sanger.ac.uk.
  • Mellor K; Parasites and Microbes Programme, Wellcome Sanger Institute, Hinxton, UK.
  • Cohen R; ACTIV, Association Clinique et Thérapeutique Infantile du Val-de-Marne, Saint Maur-des-Fossés, France; GPIP, Groupe de Pathologie Infectieuse Pédiatrique, Paris, France; AFPA, Association Française de Pédiatrie Ambulatoire, Saint-Germain-en-Laye, France; Université Paris Est, IMRB-GRC GEMINI, Crétei
  • Alonso AR; Department of RDI Microbiology, Institut de Recerca Sant Joan de Deu, Hospital Sant Joan de Deu, Barcelona, Spain; School of Medicine, Universitat Internacional de Catalunya, Barcelona, Spain; Spanish Network of Epidemiology and Public Health, CIBERESP, Instituto de Salud Carlos III, Madrid, Spain.
  • Belman S; Parasites and Microbes Programme, Wellcome Sanger Institute, Hinxton, UK.
  • Kumar N; Parasites and Microbes Programme, Wellcome Sanger Institute, Hinxton, UK.
  • Hawkins PA; Rollins School Public Health, Emory University, Atlanta, GA, USA.
  • Gladstone RA; Department of Biostatistics, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway.
  • von Gottberg A; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, Johannesburg, South Africa.
  • Veeraraghavan B; Department of Clinical Microbiology, Christian Medical College, Vellore, India.
  • Ravikumar KL; Central Research Laboratory, Kempegowda Institute of Medical Sciences, Bangalore, India.
  • Kandasamy R; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Churchill Hospital, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK; School of Women and Children's Health, University of New South Wales, Sydney, NSW, Australia; Discipline of Paediatrics and Child Health, School
  • Pollard SAJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Churchill Hospital, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
  • Saha SK; Child Health Research Foundation, Dhaka, Bangladesh.
  • Bigogo G; Kenya Medical Research Institute, Kisumu, Kenya.
  • Antonio M; WHO Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at The London School of Hygiene & Tropical Medicine, Fajara, The Gambia.
  • Kwambana-Adams B; WHO Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at The London School of Hygiene & Tropical Medicine, Fajara, The Gambia; NIHR Global Health Research Unit on Mucosal Pathogens, Division of Infection and Immunity, University College London, London,
  • Mirza S; Microbiology and Immunology Laboratory, Department of Biology, Lahore University of Management Sciences, Lahore, Pakistan.
  • Shakoor S; Department of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan.
  • Nisar I; Department of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan.
  • Cornick JE; Malawi-Liverpool-Wellcome-Trust, Blantyre, Malawi; Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.
  • Lehmann D; Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, The University of Western Australia, Perth, WA, Australia.
  • Ford RL; Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea.
  • Sigauque B; Centro de Investigação em Saúde da Manhiça, Maputo, Mozambique.
  • Turner P; Cambodia Oxford Medical Research Unit, Angkor Hospital for Children, Siem Reap, Cambodia; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Moïsi J; Agence de Médecine Préventive, Abidjan, Côte d'Ivoire.
  • Obaro SK; Division of Pediatric Infectious Disease, University of Nebraska Medical Center Omaha, Omaha, NE, USA; International Foundation against Infectious Diseases in Nigeria, Abuja, Nigeria.
  • Dagan R; Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Diawara I; Department of Microbiology, Faculty of Medicine and Pharmacy of Casablanca, Hassan II University of Casablanca, Casablanca, Morocco; National Reference Laboratory, Mohammed VI University of Health Sciences, Casablanca, Morocco.
  • Skoczynska A; Department of Epidemiology and Clinical Microbiology, National Medicines Institute, Warsaw, Poland.
  • Wang H; Peking University People 's Hospital, Beijing, China.
  • Carter PE; Institute of Environmental Science and Research Limited, Kenepuru Science Centre, Porirua, New Zealand.
  • Klugman KP; Rollins School Public Health, Emory University, Atlanta, GA, USA.
  • Rodgers G; Pneumonia Program, Bill & Melinda Gates Foundation, Seattle, WA, USA.
  • Breiman RF; Rollins School Public Health, Emory University, Atlanta, GA, USA; Emory Global Health Institute, Emory University, Atlanta, GA, USA.
  • McGee L; Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Bentley SD; Parasites and Microbes Programme, Wellcome Sanger Institute, Hinxton, UK.
  • Muñoz-Almagro C; Department of RDI Microbiology, Institut de Recerca Sant Joan de Deu, Hospital Sant Joan de Deu, Barcelona, Spain; School of Medicine, Universitat Internacional de Catalunya, Barcelona, Spain; Spanish Network of Epidemiology and Public Health, CIBERESP, Instituto de Salud Carlos III, Madrid, Spain.
  • Varon E; National Reference Center for Pneumococci, Centre Hospitalier Intercommunal de Créteil, Créteil, France.
Lancet Microbe ; 3(10): e735-e743, 2022 10.
Article en En | MEDLINE | ID: mdl-35985351
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones Neumocócicas / Streptococcus pneumoniae Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Lancet Microbe Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones Neumocócicas / Streptococcus pneumoniae Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Lancet Microbe Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido